21Shares has listed a physically backed Bitcoin–Gold exchange-traded product on the London Stock Exchange, offering combined exposure to BTC and allocated gold in a single security. The move aims to simplify diversified allocations for investors seeking crypto and precious-metal exposure.
21Shares submitted an amended S-1 with the SEC on Dec. 23, 2025, reiterating its intention to launch a Dogecoin ETF. The update arrives while existing DOGE ETFs continue to show zero inflows, underscoring weak initial demand.
Crypto.com and 21Shares announced a strategic partnership to create a private CRO trust and pursue a future exchange-traded fund tied to the Cronos ecosystem. The move aims to broaden regulated, institutional access to Cronos-based assets.
21Shares filed an updated prospectus with the U.S. SEC for an XRP ETF to be listed under ticker TOXR, moving the product closer to launch. The filing comes as other issuers such as Canary, Grayscale, and Bitwise also pursue XRP funds.
21Shares launched the first 2x leveraged SUI ETF on Nasdaq after SEC approval, offering traders amplified exposure to the Sui token. The product expands regulated access to SUI but carries the usual leverage risks for short-term strategies.
21Shares updated its spot Dogecoin ETF filing with the SEC, clarifying fees and other operational details ahead of a planned launch later this month alongside Grayscale and Bitwise. The disclosure could support DOGE liquidity and investor confidence as the token continues its rally.
21Shares launched a leveraged Dogecoin ETF on Nov. 20, 2025, following the close of its acquisition of FalconX. The product aims to offer amplified exposure to DOGE while leveraging FalconX’s trading and custody capabilities.
21Shares has cross-listed six additional crypto exchange-traded products (ETPs) on Nasdaq Stockholm, expanding local access for Nordic investors. The move strengthens the issuer’s presence in regulated European markets and could improve liquidity and investor choice.